Doxycycline Postexposure Prophylaxis for STIs in Women - Uncertain Benefit, Urgent Need

N Engl J Med. 2023 Dec 21;389(25):2389-2390. doi: 10.1056/NEJMe2311948.

Author

Jeanne Marrazzo¹

Affiliation

¹ From the National Institutes of Health, Bethesda, MD.

PMID: 38118030
DOI: 10.1056/NEJMe2311948

No abstract available

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents* / administration & dosage
Anti-Infective Agents* / therapeutic use
Doxycycline* / administration & dosage
Doxycycline* / therapeutic use
Female
HIV Infections / drug therapy
HIV Infections / prevention & control
Health Services Needs and Demand
Humans
Post-Exposure Prophylaxis* / methods
Sexually Transmitted Diseases* / drug therapy
Sexually Transmitted Diseases* / prevention & control

Substances

Anti-Bacterial Agents
Doxycycline
Anti-Infective Agents